These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9128266)

  • 1. Telomerase expression in human breast cancer with and without lymph node metastases.
    Nawaz S; Hashizumi TL; Markham NE; Shroyer AL; Shroyer KR
    Am J Clin Pathol; 1997 May; 107(5):542-7. PubMed ID: 9128266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase activity in human breast tumors.
    Hiyama E; Gollahon L; Kataoka T; Kuroi K; Yokoyama T; Gazdar AF; Hiyama K; Piatyszek MA; Shay JW
    J Natl Cancer Inst; 1996 Jan; 88(2):116-22. PubMed ID: 8537972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of telomerase expression in diagnosis and treatment of breast tumor].
    Qiu XG; Liu YP; Pu QT; Gu QH; Han JJ
    Ai Zheng; 2002 Nov; 21(11):1241-3. PubMed ID: 12526225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates.
    Sugino T; Yoshida K; Bolodeoku J; Tahara H; Buley I; Manek S; Wells C; Goodison S; Ide T; Suzuki T; Tahara E; Tarin D
    Int J Cancer; 1996 Aug; 69(4):301-6. PubMed ID: 8797872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen gene expression and telomerase activity in breast cancer patients: possible relationship to steroid hormone receptors.
    Mohajeri A; Zarghami N; Pourhasan Moghadam M; Alani B; Montazeri V; Baiat A; Fekhrjou A
    Oncol Res; 2011; 19(8-9):375-80. PubMed ID: 22329196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteine proteinase inhibitor cystatin A in breast cancer.
    Kuopio T; Kankaanranta A; Jalava P; Kronqvist P; Kotkansalo T; Weber E; Collan Y
    Cancer Res; 1998 Feb; 58(3):432-6. PubMed ID: 9458085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer.
    Hoos A; Hepp HH; Kaul S; Ahlert T; Bastert G; Wallwiener D
    Int J Cancer; 1998 Feb; 79(1):8-12. PubMed ID: 9495350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of telomerase activity in breast masses by fine-needle aspiration.
    Pearson AS; Gollahon LS; O'Neal NC; Saboorian H; Shay JW; Fahey TJ
    Ann Surg Oncol; 1998 Mar; 5(2):186-93. PubMed ID: 9527273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancer.
    Won HS; Lee KE; Sung SH; Choi MY; Jo JY; Nam EM; Mun YC; Seong CM; Lee SN
    Tumori; 2014; 100(1):80-6. PubMed ID: 24675496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative determination of telomerase activity in breast cancer and benign breast diseases.
    Simícková M; Nekulová M; Pecen L; Cernoch M; Vagundová M; Pacovský Z
    Neoplasma; 2001; 48(4):267-73. PubMed ID: 11712677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of FBP1 and LDHB in fibroadenomas and invasive breast cancers.
    Yustisia I; Amriani R; Cangara H; Syahrijuita S; Alfian Zainuddin A; Natsir R
    Breast Dis; 2021; 40(4):251-256. PubMed ID: 34092577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases.
    Bulut AS; Erden E; Sak SD; Doruk H; Kursun N; Dincol D
    Virchows Arch; 2005 Jul; 447(1):24-30. PubMed ID: 15947943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity and survival of patients with node-positive breast cancer.
    Clark GM; Osborne CK; Levitt D; Wu F; Kim NW
    J Natl Cancer Inst; 1997 Dec; 89(24):1874-81. PubMed ID: 9414175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the breast cancer metastasis suppressor gene, BRMS1, in human breast carcinoma: lack of correlation with metastasis to axillary lymph nodes.
    Kelly LM; Buggy Y; Hill A; O'Donovan N; Duggan C; McDermott EW; O'Higgins NJ; Young L; Duffy MJ
    Tumour Biol; 2005; 26(4):213-6. PubMed ID: 16006775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Telomerase activity in infiltration ductal carcinoma of breast].
    Wu S; Liu Z; Sun H
    Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):515-6. PubMed ID: 10923461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between axillary lymph node status and Ki67 labeling index in triple-negative medullary breast carcinoma.
    Chu Z; Lin H; Liang X; Huang R; Tang J; Bao Y; Jiang J; Zhan Q; Zhou X
    Jpn J Clin Oncol; 2015 Jul; 45(7):637-41. PubMed ID: 25862826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.
    Ahmad A; Hanby A; Dublin E; Poulsom R; Smith P; Barnes D; Rubens R; Anglard P; Hart I
    Am J Pathol; 1998 Mar; 152(3):721-8. PubMed ID: 9502414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and Predictors of Axillary Lymph Node Metastases in Iranian Women with Early Breast Cancer.
    Sandoughdaran S; Malekzadeh M; Mohammad Esmaeil ME
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1617-1620. PubMed ID: 29936787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity and lymphovascular invasion in breast cancer.
    Mokbel KM; Parris CN; Ghilchik M; Amerasinghe CN; Newbold RF
    Eur J Surg Oncol; 2000 Feb; 26(1):30-3. PubMed ID: 10718176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.